Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions

To evaluate the long-term results after recanalization of coronary chronic total occlusions.

Completed

Looking for future studies?

Key information

Conditions

Coronary Artery Disease Angina Pectoris Angina, Stable Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Chest Pain Coronary Disease Heart Diseases Ischemic Heart Disease Myocardial Ischemia Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Stable Angina Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Ulm

Ulm, 89081, Germany

About this study

Patients with successful recanalization of coronary chronic total occlusions are followed during a period of 5 years to demonstrate safety and efficacy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

coronary artery disease
chronic total occlusion

Exclusion criteria

no written informed consent

Treatment and study plan

stent or scaffold

Device

implantation of a CE certified drug-eluting stent, bare-metal stent or scaffold

Primary outcomes

Major adverse cardiac events

Time frame: 1-5 years

Sponsors and collaborators

Lead sponsor

University of Ulm

Other

Registry information

Acronym: CSI-Ulm-CTO

Important dates

Study start: 2014
Primary completion: 2018
Study completion: 2018
First posted: Jun 12, 2014
Registry last updated: Apr 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed